WO2026037433 - ECTEINASCIDINS DERIVATIVE, LIGAND-DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/037433
Publication Date
19.02.2026
International Application No.
PCT/CN2025/115452
International Filing Date
18.08.2025
Title **
[English]
ECTEINASCIDINS DERIVATIVE, LIGAND-DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF
[French]
DÉRIVÉ D'ECTEINASCIDINES, CONJUGUÉ LIGAND-MÉDICAMENT ET SON UTILISATION PHARMACEUTIQUE
[Chinese]
海鞘素类衍生物、配体-药物偶联物及其医药用途
Applicants **
GAN & LEE PHARM CO LTD
Inventors
SUN, Yingjie
SHENG, Haitong
ZHANG, Jianhao
LI, Shuang
JIAO, Jiao
CHE, Liming
WANG, Jiaxing
Priority Data
202411124134.4
16.08.2024
CN
202411240899.4
05.09.2024
CN
202411466062.1
21.10.2024
CN
202510338506.1
21.03.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3820 | |
| EPO | Filing, Examination, Granting | 24519 | |
| Japan | Filing, Examination, Granting | 2575 | |
| South Korea | Filing, Examination, Granting | 3062 | |
| USA | Filing, Examination, Granting | 7690 |
Total:
41,666
Contact Us
Abstract[English]
Provided are a ecteinascidins derivative, a ligand-drug conjugate, a pharmaceutical composition containing the ecteinascidins derivative or conjugate, and a corresponding pharmaceutical use thereof.[French]
L'invention concerne un dérivé d'ecteinascidines, un conjugué ligand-médicament, une composition pharmaceutique contenant le dérivé ou le conjugué d'ecteinascidines, et une utilisation pharmaceutique correspondante de celui-ci.[Chinese]
提供一种海鞘素类衍生物、配体-药物偶联物及其包含所述海鞘素类衍生物或偶联物的药物组合物、以及相应的医药用途。